R&D A patient-first mindset for change May marks World Clinical Trials Day, bringing awareness to trials and the vital role they play.
R&D Beyond proof of concept: Alzheimer’s and the next chapter of... Research has demonstrated that some individuals at elevated risk of Alzheimer's disease can be identified before symptoms emerge.
Patients Sponsored From insight to impact: Why the patient voice will redefine ... Is patient-centred trial design becoming a strategic advantage for mid-size pharma, helping cut risk, improve timelines, and engage patients?
R&D Navigating the new ICH E6 (R3): Key changes for sponsors These new regulations for running clinical trials in the UK will be a legal requirement from 28th April 2026.
Patients Putting patients first: 5 strategic shifts making clinical t... From gamified digital platforms to remote sample collection and agile site activation, sponsors are reimagining trial design.
R&D Mind the gap: The need for gender-specific outcome measureme... It is well documented that women face delayed diagnoses, mischaracterised symptoms, and experience more years of ill-health compared to men.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.